<p dir="ltr">The production cycle of lactating dairy cattle consists of physiological adaptations and changes in body tissue reserves as energy and protein requirements shift and may not be able to be met by feed intake. Tissue reserves are mobilized in early lactation and accreted thereafter, which can be used as a pool of labile amino acids and energetic substrates used at the beginning of the subsequent lactation. Nutritional strategies can be employed to mitigate extensive tissue loss and gain as a management tool to enhance dairy performance. The first study's objective was to evaluate the effects of high oleic soybean oil (HOSO) supplementation on milk production, body composition, and apparent total tract digestibility variables. A cross-over design with 21-d periods was employed with thirty Holstein cows (n = 16 primiparous, n = 14 multiparous at 87 ± 26 DIM at start of trial). Treatments consisted of a control (CON) with no added soybean oil and a HOSO diet with 1.5% diet dry matter (DM) of high oleic soybean oil added. Milk production and DM were collected on the last 7 d of each period. Body weights (BW), milk, and fecal samples were collected on the last 3 d of each period. Ultrasound scans of the <i>longissimus dorsi </i>muscle and body condition scores (BCS) were collected on the last d of each period. Dry matter intake, milk production, and milk component yields were not impacted by HOSO supplementation, although milk fat concentration tended to be greater for HOSO cows. A treatment by parity interaction and treatment by parity tendency were observed for BCS and BW, respectively, with multiparous HOSO cows having increased BCS and BW compared to CON with no effect on primiparous cows. Compared with CON, HOSO increased backfat depth (BFD) by 0.44 mm as well as apparent total tract fat digestibility by 12 percentage units with no differences observed in muscle<i> </i>depth. The second study’s objective was to evaluate changes in <i>longissimus dorsi </i>depth and its impact on production parameters in cows with two muscle phenotypes. Forty multiparous dairy cows were categorized into two muscle phenotype groups of high muscle (HM; n = 18) and low muscle (LM; n = 22) as determined by <i>longissimus dorsi </i>depth immediately after parturition. Ultrasound images of the <i>longissimus dorsi </i>and body weights were collected monthly from 0 to 300 DIM. Blood samples were collected from the coccygeal vessels on d 7, 150, and 300 and analyzed for 3-methylhistidine (3-MH), creatinine, non-esterified fatty acids (NEFA), and insulin. Milk weight data was collected daily using AfiFarm and milk components were collected from monthly DHIA test day data. Neither BW nor BFD were different between HM and LM cows at any timepoint, although, a DIM effect was observed. Cows lost BW from 0 to 60 DIM and BFD from 0 to 90 DIM and began increasing thereafter until 300 DIM. A muscle group by DIM interaction was observed where HM cows had more <i>longissimus dorsi </i>depth (LDD) at 0 and 300 DIM and tended to have more at 60 DIM compared to LM cows, with no differences at any other timepoint. In both muscle groups, LDD was decreased from 0 to 60 DIM but substantial LDD accretion did not occur until 240 DIM. No differences were observed between muscle groups for blood analytes; however, significant DIM effects were observed and corresponded to the observed changes in body tissue reserves. Daily milk production was grouped by stage of lactation with DIM groups consisting of early lactation from 0 to 60 DIM, mid-lactation from 60-240 DIM, and late lactation from 240 to 300 DIM. There was a muscle group by DIM group interaction for daily milk yield as HM cows produced more milk/d in early and mid-lactation but produced less milk in late lactation compared to LM cows. The results of these studies indicate that oleic acid can be supplemented to lactating dairy cattle to increase adipose tissue reserves with no effect on muscle reserves. This could potentially be caused by the lack of muscle accretion throughout mid-lactation whereas adipose tissue is gained. These results also describe that nutrition and muscle phenotype play a role in body composition throughout lactation.</p>

No description available.

No description available.

A leptospirose humana é uma doença infecciosa aguda de amplo espectro clínico e que cursa com alterações metabólicas e dislipidêmicas envolvendo colesterol total e frações, triglicerídeos e ácidos graxos não esterificados (AGNEs). Dentre os mecanismos celulares envolvidos na sua fisiopatologia encontram-se a inibição da enzima Na, K ATPase pela endotoxina GLP e a lipotoxicidade, ambos agravados pela redução dos níveis circulantes da albumina, molécula que exerce um papel fundamental na adsorção de moléculas lipídicas. Neste estudo observacional, determinamos as concentrações séricas de bilirrubina, creatinina e albumina e, pela técnica de cromatografia líquida de alta performance, a concentração sérica dos AGNEs de cadeia longa (C16: C18) de 27 pacientes com síndrome de Weil durante o período de internação hospitalar, dos quais cinco vieram a falecer. Verificamos correlações significantes (p<0,05) ao longo da internação hospitalar, nas concentrações séricas de marcadores bioquímicos de gravidade da doença (bilirrubina, creatinina e albumina), AGNEs, ácido oléico e ácido linoléico, e relação molar ácido oléico/ albumina, com r (Pearson) de -0,7981, -0,7699, 0,9014, -0,8795 -0,9816, -0,9694, -0,9821, respectivamente. A relação molar ácido oléico/ albumina e ácido oléico+ linoléico/albumina foi significantemente mais elevada nos pacientes que faleceram (p<0,001), retornando aos valores semelhantes aos do grupo controle nos pacientes que evoluíram para a cura. Na análise por Curva Roc, a relação molar ácido oléico/albumina se mostrou um bom teste preditivo, com valor de corte 0,705 associado com maior especificidade e sensibilidade prognóstica. Nossos resultados sugerem que a utilização parenteral da albumina humana em pacientes com leptospirose pode ser uma potente ferramenta terapêutica nos casos mais graves ao interferir positivamente no resgate do equilíbrio bioquímico das relações molares ácido oléico/ albumina e ácido oléico+linoléico/albumina.

A leptospirose humana é uma doença infecciosa aguda de amplo espectro clínico e que cursa com alterações metabólicas e dislipidêmicas envolvendo colesterol total e frações, triglicerídeos e ácidos graxos não esterificados (AGNEs). Dentre os mecanismos celulares envolvidos na sua fisiopatologia encontram-se a inibição da enzima Na, K ATPase pela endotoxina GLP e a lipotoxicidade, ambos agravados pela redução dos níveis circulantes da albumina, molécula que exerce um papel fundamental na adsorção de moléculas lipídicas. Neste estudo observacional, determinamos as concentrações séricas de bilirrubina, creatinina e albumina e, pela técnica de cromatografia líquida de alta performance, a concentração sérica dos AGNEs de cadeia longa (C16: C18) de 27 pacientes com síndrome de Weil durante o período de internação hospitalar, dos quais cinco vieram a falecer. Verificamos correlações significantes (p<0,05) ao longo da internação hospitalar, nas concentrações séricas de marcadores bioquímicos de gravidade da doença (bilirrubina, creatinina e albumina), AGNEs, ácido oléico e ácido linoléico, e relação molar ácido oléico/ albumina, com r (Pearson) de -0,7981, -0,7699, 0,9014, -0,8795 -0,9816, -0,9694, -0,9821, respectivamente. A relação molar ácido oléico/ albumina e ácido oléico+ linoléico/albumina foi significantemente mais elevada nos pacientes que faleceram (p<0,001), retornando aos valores semelhantes aos do grupo controle nos pacientes que evoluíram para a cura. Na análise por Curva Roc, a relação molar ácido oléico/albumina se mostrou um bom teste preditivo, com valor de corte 0,705 associado com maior especificidade e sensibilidade prognóstica. Nossos resultados sugerem que a utilização parenteral da albumina humana em pacientes com leptospirose pode ser uma potente ferramenta terapêutica nos casos mais graves ao interferir positivamente no resgate do equilíbrio bioquímico das relações molares ácido oléico/ albumina e ácido oléico+linoléico/albumina.

Thesis (MSc)--Stellenbosch University, 2012. / ENGLISH ABSTRACT: Background:Obesity is a growing global burden; current studies have projected the prevalence of obese / overweight individuals to increase to ~1.35 billion by 2030. A number of factors contribute to cardiovascular diseases, of which the focus of this study is what effect an increased level of free fatty acids has on the flux through the hexosamine biosynthetic pathway (HBP). It has been widely proven that an increased flux through the HBP causes an increase in protein O-GlcNAcylation, which leads to increased reactive oxygen species (ROS) production as well as an increase in cell death (apoptosis). Methods: For the purpose of this study a cell model was used. H9c2 cardiomyoblasts were cultured in 5ml Dulbecco‟s Modified Eagles Medium (DMEM) supplemented with 10% foetal bovine serum and 1% penicillin-streptomycin. The cells were then exposed to 0.25mM monounsaturated fatty acid (oleic acid) for 24, 48 and 72 hours respectively. The cultured cells were then evaluated to assess the degree ROS production, overall O-GlcNAcylation and cell death (apoptosis and necrosis), using flow cytometry and immunofluorescence microscopy. Results: We found that oleic acid causes a significant decrease in ROS production at the 48 hour time point when analysed on the flow cytometer, which indicates that oleic acid is metabolized by the cells in a independent manner. Oleic acid also caused a significant decrease in cell death at all the time intervals. With regard to the HBP, oleic acid activates this pathway but causes downstream cardioprotective effects that do not necessarily occur along this pathway. Conclusion: This study explored whether a monounsaturated fatty acid, oleic acid, is able to act as a novel cardioprotective agent. The in vitro data supports this concept and we showed that it is able to blunt oxidative stress and cell death. It was also found that although oleic acid activated the HBP, it did not mediate its protective effects via this pathway only. / AFRIKAANSE OPSOMMING: Agtergrond: Vetsug is 'n groeiende wêreldlas; huidige studies voorspel dat die voorkoms van vetsugtige / oorgewig individue toe sal neem tot ~1.35 biljoen teen 2030. Alhoewel verskeie faktore tot kardiovaskulêre siektes bydra is die fokus van hierdie studie om die effek van verhoogde vryvetsuurvlakke op die fluks deur die heksosamienbiosintestiese weg (HBW) te ondersoek. Dit is reeds bewys dat verhoogde fluks deur die HBW 'n verhoging in proteïen O-GlcNAsilering lei, wat verder tot verhoogde reaktiewe suusrtofspesies (ROS) vorming aanleiding gee en ook seldood (apoptose) verhoog. Metodes:'n Selmodel is vir die doel van hierdie studie gebruik. H9c2 kardiomioblaste is in 5ml Dulbecco's Modified Eagles Medium (DMEM) gekweek en gesupplementeer met 10% fetale beesserum en 1% penisillien-streptomysien. Die selle is blootgestel aan 'n 0.25mM mono onversadigde vetsuur (oleïensuur ) vir 24, 48 en 72 uur onderskeidelik. Die gekweekte selle is gevolglik ondersoek vir die graad van ROS ontwikkeling, algehele O-GlcNAsilering en seldood (apoptosis en nekrose), deur van vloeisitometrie en immunofluoresensie mikroskopie gebruik te maak. Resultate: Ons het bevind dat oleïensuur 'n betekenisvolle verlaging in ROS ontwikkeling teen 48 uur soos bepaal deur die vloeisitometer, veroorsaak. Dit wys daarop dat oleïensuur deur die selle op 'n onafhanklike wyse gemetaboliseer is. Oleïensuur het ook 'n betekenisvolle verlaging in seldood by alle tydsintervalle veroorsaak. Met betrekking tot die HBW het oleïensuur hierdie weg geaktiveer maar afstroom kardiobeskermings effekte versoorsaak wat nie noodwendig langs hierdie weg onstaan nie. Gevolgtrekking:Hierdie studie het die moontlikheid van 'n mono-onversadige vetsuur, oleïensuur, om op te tree as 'n nuwe kardiobeskermingsmiddel ondersoek. Die in vitro data ondersteun hierdie konsep en hier is aangetoon dat dit wel oksidatiewe stres en seldood onderdruk. Daar is verder bevind dat alhoewel oleïensuur die HBW aktiveer dit nie die beskermings effekte alleenlik via hierdie weg medieer nie.

O fluido multifásico complexo (suco de açaí) tem uma forte interação com membranas poliméricas ou cerâmicas de microfiltração e a formação de incrustação depende da composição e das condições de dinâmica de fluidos. Neste estudo experimental foi investigada a influência dos dois principais ácidos graxos presentes no açaí, ácido oleico e ácido palmítico, em misturas com água e no processo de microfiltração tangencial com membranas cerâmicas de alumina com um tamanho de poro nominal de 0,2 \'mü\'m. Mediu-se o fluxo de permeado em função do tempo, nas pressões transmembranas de 300 kPa, 400 kPa e 500 kPa. Para o fluxo da corrente de alimentação foram encontrados valores de Reynolds numa faixa de 9500 a 31000. Cada amostra de misturas de água/ácido oleico, água/ácido palmítico e água/ácidos oleico e palmítico, foi estudada em três séries de ensaios realizados durante 180 minutos e 72 minutos para a mistura água/ácido palmítico, a temperatura em 25 ºC. Analisou-se as incrustações resultantes e as fortes interações fluido/membrana utilizando o modelo de resistência em série e imagens tomadas por microscopia eletrônica de varredura (MEV). Os melhores resultados de permeado encontrados para a mistura de água/ácido oleico foram para Re = 33000, no entanto, resultados satisfatórios foram encontrados para Re = 20000. Agora para a água/ácido palmítico foram encontrados para Re = 20000. Os melhores resultados de permeado para a mistura água/ácidos oleico e palmítico foram para Re = 31000. De acordo com os resultados das resistências, a mistura água/ácido causa um bloqueio dos poros da membrana, resultando em uma maior diminuição do fluxo transmembrana. A limpeza foi eficiente para reduzir a resistência associada com a polarização. / The complex fluid multiphase (açaí juice) has a strong interaction with polymeric or ceramic membranes for microfiltration fouling and its formation depends on the fluid composition and fluid dynamics conditions. In this experimental study was investigated the influence of two major fatty acids present in açaí, oleic acid and palmitic acid in mixtures with water and in the process of crossflow microfiltration with ceramic membranes. In the separation process is used alumina ceramic membrane with a nominal pore size of 0.2 micrometers. The permeate flux was measured in function of time using the 300 kPa, 400 kPa and 500 kPa for the transmembrane pressure. The flow of feed stream and its respective value of Reynolds were in range of: 8900-3300. For each sample of mixtures oleic acid/water and palmitic acid/water and palmitic acid, oleic acid/ water, three series of experiments were conducted for 180 minutes and 72 minutes for mixture palmitic acid/water at temperature in 25 Celcius. For analyze of fouling resulting from strong interactions fluid/membrane was used the model of resistance in series and images taken via scanning electron microscopy (SEM). The best results for mixing oleic acid/water were to Re = 33000, however, satisfactory results were found for Re = 20000. Now for the palmitic acid/water were found to Re = 20000. For mixture palmitic acid, oleic acid/ water were found to Re = 31000. According to the results of the resistances, the mixture oleic acid/water cause a blockage of the pores of the membrane resulting in a greater decrease of the transmembrane flow. The cleaning is efficient for reducing the resistance associated with the polarization.

INTRODUÇÃO. O termo Lesão Pulmonar Aguda (LPA) é usado para descrever a resposta pulmonar à lesão que ocorre diretamente ou indiretamente nos pulmões. A quebra da barreira alvéolo-capilar determina o influxo de líquido rico em proteínas para dentro dos espaços alveolares, sendo necessária a reabsorção desse líquido no processo de resolução da LPA. A infusão intravenosa de Ácido Oleico (AO) em ratos provoca agudamente edema alveolar difuso e focos hemorrágicos intra-alveolares, sendo um bom modelo de indução. Estudos relatam que o Azul de Metileno (AM) atenua tais lesões, com efeito protetor, no tecido pulmonar, e reduz o edema presente na LPA em animais com sepse através da inibição da guanilato ciclase solúvel (GCs), uma enzima ativadora da via NO-GMPc. OBJETIVO. Estudar a repercussão da inibição da GCs pelo AM na permeabilidade capilar pulmonar ministrando-o antes e após a indução da lesão pulmonar por AO. MÉTODO. Ratos Wistar foram divididos em 5 grupos: Sham com infusão de salina em bolus; AM com infusão de AM por 2h; AO com infusão de AO em bolus, AM/AO com infusão de AM por 2h, sendo que, após 5 min do início, recebeu AO simultaneamente em bolus e AO/AM com infusão de AO em bolus e, após 2h, infusão de AM por mais 2h. Após 4h foi realizada a coleta de materiais (sangue, lavado bronco-alveolar e tecido pulmonar) para análise do NO plasmático e tecidual, gasometria arterial, cálculo do peso úmido/peso seco (PU/PS) e histologia do tecido pulmonar de todos os grupos. A estatística utilizada foi a análise de variância (one-way ANOVA) com p<0.05. RESULTADO. Não foi encontrado hipoxemia grave após 4h de lesão. O grupo AO apresenta um aumento no número de proteínas no lavado bronco-alveolar e na relação PU/PS comparado aos grupos controle: Sham e AM, confirmando a presença de lesão e alteração de permeabilidade pulmonar. Os grupos tratados com AM apresentaram melhora na permeabilidade pulmonar, porém, apenas o grupo pré-tratamento (AM/AO) apresentou diferença estatística na redução do extravasamento de proteínas no lavado. Não foram encontradas diferenças significativas no NO plasmático e tecidual. Na microscopia, a congestão capilar foi intensa, acompanhada de múltiplos focos de edema alveolar, exsudato intra-alveolar proteico, áreas de hemorragia e infiltrado inflamatório neutrofílico, tanto no interstício quanto nos septos alveolares.Os grupos tratados com AM apresentaram diminuição das áreas de edema, exsudação e hemorragia, porém, com maior evidência no grupo AM/AO. CONCLUSÃO. O AM diminui a permeabilidade pulmonar quando administrado de maneira precoce amenizando os danos causados pela LPA induzida por AO. / BACKGROUND. The term Acute Lung Injury (ALI) is used to describe the response to lung injury that occurs directly or indirectly in the lungs. The rupture of the alveolar - capillary barrier determines the influx of protein-rich fluid into the alveolar spaces, the reabsorption of this fluid in the process of resolving the ALI is required. Intravenous infusion of oleic acid (OA) in rats acutely causes diffuse alveolar edema and intra-alveolar hemorrhagic foci, being a good role model induction. Studies have reported that Methylene Blue (MB) attenuates such injuries, with a protective effect in lung tissue and reduce edema present in the ALI present in with sepsis by inhibition of soluble guanylate cyclase (sGC), an activator of the enzyme NO- cGMP pathway. OBJECTIVE. To study the effect of inhibition of sGC by MB in pulmonary capillary permeability ministering to the before and after induction of lung injury by OA. METHOD. Wistar rats were divided into 5 groups: Sham infused with saline bolus, MB infused with MB for 2hrs, OA infused with OA bolus, MB/OA infused with MB for 2hrs, and after 5 min from the beginning, simultaneously received OA bolus and OA/MB infused with OA bolus and after 2hrs, MB infusion for 2hrs. After 4hrs the collection of materials was performed (blood, bronchoalveolar lavage and lung tissue) for analysis of plasma and tissue NO, arterial blood gases, calculation of the wet weight/dry weight (WW/DW) and histology of lung tissue from all groups. The statistic used was analysis of variance (one-way ANOVA) with p<0.05. RESULTS. Not found severe hypoxemia after 4hrs of injury. The OA group shows an increase in the number of proteins in bronchoalveolar lavage and in WW/DW ratio compared to the control groups: Sham and MB, confirming the presence of injury and alterations of lung permeability. The groups treated with MB showed improvement in lung permeability, however, only the pretreatment group (MB/OA) showed statistical significance in reducing the leakage of protein in the lavage. No significant differences were found in plasma and tissue NO. In microscopy, capillary congestion was intense, accompanied by multiple foci of alveolar edema, intra-alveolar proteinaceous exudates, areas of hemorrhage and neutrophilic inflammatory infiltrate in both the interstitium and in the alveolar septa. The groups treated with MB showed reduction in areas of edema, exudation and hemorrhage, however, most obviously in MB/OA group. CONCLUSION. The MB decreases lung permeability when administered as early as possible, mitigating the damage caused by OA-induced ALI.

A administração tópica do ácido 5-aminolevulínico (5-ALA) tem se destacado na Terapia Fotodinâmica (TFD) do câncer de pele pela eficiência no tratamento de tumores e pelos reduzidos efeitos colaterais fototóxicos. Entretanto, esta eficácia é limitada devido à baixa penetração do 5-ALA na pele. Uma proposta para aumentar a penetração do 5-ALA na pele é a utilização de promotores de absorção cutânea, que visam alterar a barreira cutânea para várias moléculas bioativas. O objetivo deste trabalho foi o desenvolvimento farmacotécnico de formulações contendo ácido oléico (AO) como promotor de absorção cutânea, visando o aumento da penetração cutânea do 5-ALA para a TFD do câncer de pele. O fluxo in vitro de 5-ALA das formulações contendo AO (10%) foi significativamente aumentado após 12 horas de experimento, em relação às formulações sem AO, principalmente para os grupos contendo 5% e 10% de 5-ALA. A retenção no estrato córneo (EC) e na[epiderme + derme] sem EC também aumentou significativamente, mostrando um efeito promotor do AO. Foram também realizados experimentos in vivo em camundongos, com o intuito de analisar o efeito da formulação sobre a produção e o acúmulo in vivo de protoporfirina IX (PpIX) na pele. Observou-se que a presença do promotor de absorção aumentou significativamente a quantidade de PpIX extraída da pele comparado às formulações sem este aditivo. Para visualizar a presença de PpIX no tecido, realizou-se microscopia confocal das peles de animais tratados com as formulações. As imagens foram condizentes com os experimentos in vivo, observando-se um aumento da intensidade de fluorescência nas amostras de pele que foram tratadas com as formulações contendo AO. Os resultados in vitro e in vivo mostraram a potencialidade das formulações contendo AO como promotor de absorção cutânea na liberação do 5-ALA na TFD do câncer de pele. / The topical administration of 5-ALA has been distinguished on skin cancer photodynamic therapy (PDT) because of its efficiency in the treatment of tumors and the reduced phototoxic collateral effects. However, this effectiveness is limited by its low penetration in the skin. A proposal to optimize the 5-ALA penetration in the skin is the use of cutaneous penetration enhancers, which seek to alter the cutaneous barrier for many bioactive molecules. The aim of this work was the pharmaceutical development of formulations containing oleic acid (OA) as a cutaneous penetration enhancer, seeking the increase of the cutaneous penetration of 5-ALA for skin cancer PDT. The in vitro flux of 5-ALA from formulations containing OA (10% w/w) was significantly increased after 12 hours of experiment, in comparison with formulations without OA, mainly for the groups containing 5% and 10% of 5-ALA. The stratum corneum (SC) and [epidermis + dermis] without SC retention were also significantly increased, showing an enhancer effect of the fatty acid. In addition, in vivo experiments were accomplished in mice, with the purpose of analyzing the formulation effect on the PpIX production and accumulation in the skin. It was observed that the penetration enhancer\'s presence significantly increased the amount of PpIX extracted from the skin, in contrast with formulations without this addition. To visualize the PpIX presence in the tissue, confocal microscopy of the treated animal skins was made. The images were suitable with the in vivo experiments, with increased intensity of fluorescence in the tissue samples that were treated with formulations containing OA. Both in vitro and in vivo results showed the potentiality of the formulations containing OA as a cutaneous penetration enhancer for 5-ALA delivery on the skin cancer PDT.

Au niveau industriel, l'accès aux acides azélaïque et pélargonique, composés à forte valeur ajoutée, est possible grâce à une réaction d'ozonolyse de l'acide oléïque. Cependant, cette méthode présente certains désavantages sur le plan écologique. Le but de cette étude a donc été de développer une méthode alternative à ce procédé industriel, visant à limiter autant que possible les impacts écologiques, directs ou indirects, lors de la synthèse des acides azélaïque et pélargonique. Nous avons ainsi montré qu'un clivage en deux étapes peut être préférable à un clivage oxydant en une étape. Notre procédé propose ainsi, dans un premier temps, une dihydroxylation de la double liaison d'acides gras par une méthode connue, laquelle est suivie par un clivage oxydant en présence d'hypochlorite de sodium. Ce nouveau procédé mis au point au sein du laboratoire présente l'avantage de ne nécessiter l'emploi ni de métaux de transition, ni de solvant organique. Nous avons par la suite étudié l'hypochlorite de sodium afin de déterminer son rôle et son mode d'action dans la réaction de clivage de diols vicinaux / Industrial production of two high added value compounds called pelargonic acid and azelaic acid is made possible by the ozonolysis reaction of oleic acid. However, this method has numerous disadvantages in term of ecological impact. In this dissertation, we present an alternative to the current industrial process in order to lower direct or indirect negative environmental impacts when synthetizing azelaic and pelargonic acids. At first we demonstrate that a two-step oxidative cleavage may be preferable to a one-step cleavage. Then we present in details a novel synthesis method which starts with the dihydroxylation of the fatty acids double bond using a well known method, followed by the oxidative cleavage in presence of sodium hypochlorite. One notes that this original fabrication process developed in our laboratory does not require to use transition metals nor organic solvents. As a complement to this work, we have subsequently studied the sodium hypochlorite to determine its role and operating mode in the vicinal diols cleavage reaction